Award recordCONTRACT

ARIAD PHARMACEUTICALS, INC.

PIID VA26018J2120· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $284,257 net obligations· UEI EVMMLCKBZS47· MA

Description

FY18 BULK FUNDED FOR ICUSLIG 15MG TABLETS. DE-OBLIGATION.

Base award description: FY18 BULK FUNDED FOR ICUSLIG 15MG TABLETS

First action · last action
2017-10-01 · 2019-05-30
Transactions
3
First transaction's obligation
$170,924
Base + all options value (sum of deltas)
$284,257
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P15A0016
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$354,959$0Base award · 2017-10-01 · this action $170,924 · running total $170,924Modification P00001 · 2018-05-14 · this action $184,035 · running total $354,959Modification P00002 · 2019-05-30 · this action -$70,702 · running total $284,257
  • Base2017-10-01+$170,924= $170,924
  • Mod P000012018-05-14+$184,035= $354,959
  • Mod P000022019-05-30-$70,702= $284,257
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-10-01+$170,924$170,924FY18 BULK FUNDED FOR ICUSLIG 15MG TABLETS
Mod P00001· FUNDING ONLY ACTION2018-05-14+$184,035$354,959FY18 BULK FUNDED FOR ICUSLIG 15MG TABLETS
Mod P00002· CLOSE OUT2019-05-30−$70,702$284,257FY18 BULK FUNDED FOR ICUSLIG 15MG TABLETS. DE-OBLIGATION.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EVMMLCKBZS47)

AwardOffice · PSC / listingNet obligationsFY
36C25219F0494252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019
36C24919N0606249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$23,004FY2019
36C25219F0450252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019
36C24919F0373249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$11,502FY2019
36C24519F0682245-NETWORK CONTRACT OFFICE 5 (36C245) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY$0FY2019
36C25219F0412252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$11,502FY2019

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26018J2120_3600_VA797P15A0016_3600 · retrieved 2026-09-26.